Elizabeth Barrett has served as our President and Chief Executive Officer and as a director since January 2019. Prior to joining UroGen, Ms. Barrett served as the Chief Executive Officer of Novartis Oncology and a member of the Novartis Executive Committee since February 2018. Prior to Novartis, ms. Barrett served at Pfizer Inc. in various leadership capacities, most recently as the Global President of Oncology and, before that, as President of Global Innovative Pharma for Europe, President of the Specialty Care Business Unit for North America, and Regional President of United States Oncology. Prior to Pfizer, Ms. Barrett was Vice President and General Manager of the Oncology Business Unit at Cephalon Inc. Ms. Barrett received an M.B.A. degree in Business Administration-Marketing from Saint Joseph s University and a B.S. from the University of Louisiana. Ms. Barrett also served on the board of directors of Sage Therapeutics, Inc. (2019-2025) and currently serves on the board of directors of Allogene Therapeutics, Inc. (since 2021). Our Board believes Ms. Barrett s service as our Chief Executive Officer and her leadership of both large organizations and growing businesses qualify her to serve on our Board.